Carl R. Lupica

Affiliations: 
National Institute on Drug Abuse 
Area:
Dopamine, cannabinoids, electrophysiology
Google:
"Carl Lupica"
Mean distance: 13.75 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wright AM, Zapata A, Hoffman AF, et al. (2021) Effects of Withdrawal from Cocaine Self-Administration on Rat Orbitofrontal Cortex Parvalbumin Neurons Expressing : Sex-Dependent Changes in Neuronal Function and Unaltered Serotonin Signaling. Eneuro
Zapata A, Lupica CR. (2021) Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior. Neuropharmacology. 192: 108604
Hoffman AF, Hwang EK, Lupica CR. (2020) Erratum: Impairment of Synaptic Plasticity by Cannabis, Δ-THC, and Synthetic Cannabinoids. Cold Spring Harbor Perspectives in Medicine. 10
Hoffman AF, Hwang EK, Lupica CR. (2020) Impairment of Synaptic Plasticity by Cannabis, Δ-THC, and Synthetic Cannabinoids. Cold Spring Harbor Perspectives in Medicine
Yano H, Adhikari P, Naing S, et al. (2020) Positive allosteric modulation of the 5-HT receptor by indole-based synthetic cannabinoids abused by humans. Acs Chemical Neuroscience
Nakamura Y, Dryanovski DI, Kimura Y, et al. (2019) Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion. Elife. 8
Hwang EK, Lupica CR. (2019) Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ-Tetrahydrocannabinol Exposure. Biological Psychiatry
Lecca D, Bader M, Tweedie D, et al. (2019) (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice. Neurobiology of Disease. 104528
Bäck S, Necarsulmer J, Whitaker LR, et al. (2019) Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats. Neuron
Bonifazi A, Yano H, Guerrero AM, et al. (2019) Novel and Potent Dopamine D Receptor Go-Protein Biased Agonists. Acs Pharmacology & Translational Science. 2: 52-65
See more...